Pattern of apoptosis by NS398, a selective COX-2 inhibitor, in hepatocellular carcinoma cell lines

Mi Kyung Park1, Moon Kyu Kim, Jung Chul Kim

  • 1Department of Immunology, School of Medicine, Kyungpook National University, Daegu, Korea.

Abstract

Insights

The cytotoxic effect of NS398 on hepatocellular carcinoma cells was independent of COX-2 expression and did not involve caspases. Further research is needed to evaluate COX-2 inhibitors for cancer prevention.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Hepatocellular carcinoma (HCC) is a significant global health concern.
  • Selective cyclooxygenase-2 (COX-2) inhibitors, like NS398, have shown potential in inhibiting the growth of COX-2 expressing HCC cells.

Purpose of the Study:

  • To investigate if the cytotoxic effect of NS398 is dependent on COX-2 expression in HCC cells.
  • To determine the involvement of caspases in NS398-induced apoptosis in HCC cells.

Main Methods:

  • RT-PCR and Western blot were used to assess COX-2 expression in SNU 423 and SNU 449 HCC cell lines.
  • MTT assays measured cytotoxicity in the presence or absence of caspase inhibitors.
  • Flow cytometry and a Cell Death ELISA kit analyzed cell cycle distribution and apoptosis.

Main Results:

  • COX-2 expression was detected in SNU 423 cells but not in SNU 449 cells.
  • NS398 induced dose- and time-dependent growth inhibition and apoptosis in both cell lines.
  • Caspase inhibitors (z-VAD-fmk and Ac-DMQD-CHO) did not attenuate the cytotoxic effect of NS398.

Conclusions:

  • The cytotoxic effects of NS398 on HCC cells are independent of COX-2 expression.
  • Caspases are not involved in NS398-induced apoptosis in these HCC cell lines.
  • The utility of COX-2 inhibitors for HCC prevention requires careful evaluation.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...